GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » EV-to-Revenue

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) EV-to-Revenue : 1.19 (As of May. 14, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Gulf Pharmaceutical Industries PSC's enterprise value is د.إ1,949 Mil. Gulf Pharmaceutical Industries PSC's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was د.إ1,638 Mil. Therefore, Gulf Pharmaceutical Industries PSC's EV-to-Revenue for today is 1.19.

The historical rank and industry rank for Gulf Pharmaceutical Industries PSC's EV-to-Revenue or its related term are showing as below:

ADX:JULPHAR' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.08   Med: 2.86   Max: 12.08
Current: 1.19

During the past 13 years, the highest EV-to-Revenue of Gulf Pharmaceutical Industries PSC was 12.08. The lowest was 1.08. And the median was 2.86.

ADX:JULPHAR's EV-to-Revenue is ranked better than
75% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.38 vs ADX:JULPHAR: 1.19

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-14), Gulf Pharmaceutical Industries PSC's stock price is د.إ0.952. Gulf Pharmaceutical Industries PSC's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was د.إ1.42. Therefore, Gulf Pharmaceutical Industries PSC's PS Ratio for today is 0.67.


Gulf Pharmaceutical Industries PSC EV-to-Revenue Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC EV-to-Revenue Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.07 3.88 2.43 1.32 1.07

Gulf Pharmaceutical Industries PSC Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.32 1.13 1.15 1.19 1.07

Competitive Comparison of Gulf Pharmaceutical Industries PSC's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Gulf Pharmaceutical Industries PSC's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gulf Pharmaceutical Industries PSC's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Gulf Pharmaceutical Industries PSC's EV-to-Revenue falls into.



Gulf Pharmaceutical Industries PSC EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Gulf Pharmaceutical Industries PSC's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1949.077/1638
=1.19

Gulf Pharmaceutical Industries PSC's current Enterprise Value is د.إ1,949 Mil.
Gulf Pharmaceutical Industries PSC's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ1,638 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gulf Pharmaceutical Industries PSC  (ADX:JULPHAR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Gulf Pharmaceutical Industries PSC's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.952/1.418
=0.67

Gulf Pharmaceutical Industries PSC's share price for today is د.إ0.952.
Gulf Pharmaceutical Industries PSC's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was د.إ1.42.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gulf Pharmaceutical Industries PSC EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Traded in Other Exchanges
N/A
Address
Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines